Narrow Ruling in Bilski Case Maintains Patentability of Diagnostics, other Biotech Inventions | GenomeWeb

NEW YORK (GenomeWeb News) — The Supreme Court today upheld the Federal Circuit Court of Appeals' determination in Bilski v. Kappos that certain business method patents are invalid, but rejected the lower court's determination that such patents must be tied to a machine or undergo a "transformation" in order to be patentable.

The decision ultimately upholds the patent eligibility of certain innovations not tied to a physical instrument, such as software, data-driven processes, and medical diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.